An exacerbation of severe asthma with fungal sensitization successfully treated with voriconazole via a reduction of the fungal burden

Allergol Int. 2019 Oct;68(4):549-551. doi: 10.1016/j.alit.2019.05.007. Epub 2019 Jun 21.

Authors

Otohiro Katsube¹, Yuta Kono¹, Ryuta Tsuzuki¹, Satoshi Yamawaki¹, Seiko Soeda¹, Masako To², Yasuo To³

Affiliations

¹ Department of Allergy and Respiratory Medicine, The Fraternity Memorial Hospital, Tokyo, Japan.
² Department of Allergy and Respiratory Medicine, The Fraternity Memorial Hospital, Tokyo, Japan; Department of Laboratory Medicine, Dokkyo Medical University, Saitama Medical Center, Saitama, Japan.
³ Department of Allergy and Respiratory Medicine, The Fraternity Memorial Hospital, Tokyo, Japan. Electronic address: ym_to@yahoo.co.jp.

PMID: 31235243
DOI: 10.1016/j.alit.2019.05.007

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antifungal Agents / therapeutic use*
Antigens, Fungal / immunology
Aspergillosis / blood
Aspergillosis / drug therapy*
Aspergillosis / immunology
Aspergillosis / microbiology
Aspergillus / drug effects
Aspergillus / immunology
Asthma / blood
Asthma / drug therapy*
Asthma / immunology
Asthma / microbiology
Bronchitis / blood
Bronchitis / drug therapy*
Bronchitis / immunology
Bronchitis / microbiology
Female
Humans
Immunoglobulin E / blood
Immunoglobulin E / immunology
Immunoglobulin G / blood
Immunoglobulin G / immunology
Voriconazole / therapeutic use*

Substances

Antifungal Agents
Antigens, Fungal
Immunoglobulin G
Immunoglobulin E
Voriconazole